Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT

Heron Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.58M -110.56M -182.02M -220.68M
Depreciation & Amortization
2.49M 2.9M 2.89M 3.02M
Stock-Based Compensation
12.96M 32.85M 42.98M 46.85M
Other Working Capital
-6.28M 12.4M 12.81M -38.23M
Other Non-Cash Items
3.2M -773K -251K 904K
Deferred Income Tax
n/a n/a n/a 1.63M
Change in Working Capital
-27.6M 16.79M -10.51M -35.08M
Operating Cash Flow
-22.53M -58.79M -146.91M -203.35M
Capital Expenditures
-1.71M -1.54M -1.82M -3.02M
Cash Acquisitions
n/a n/a 227K 32K
Purchase of Investments
-103.09M -87.66M -145.68M -129.22M
Sales Maturities Of Investments
123.48M 107.19M 143.96M 164.94M
Other Investing Acitivies
27K 13K n/a n/a
Investing Cash Flow
18.71M 18M -3.32M 32.73M
Debt Repayment
n/a 24.35M n/a 148.96M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 2K -86K n/a
Financial Cash Flow
940K 54.11M 75.06M 156.03M
Net Cash Flow
-2.88M 13.31M -75.18M -14.6M
Free Cash Flow
-24.23M -60.33M -148.74M -206.38M